Akira Ohata

Title: Akira Ohata: Innovator in Pharmaceutical Development

Introduction

Akira Ohata is a prominent inventor based in Osaka, Japan, known for his contributions to pharmaceutical innovations. With a total of 5 patents, he has made significant strides in developing medications that address urinary excretion disorders.

Latest Patents

One of his latest patents involves a Tetrahydrocarboline derivative. The objective of this invention is to provide a drug that exhibits inhibitory activity on ENPP2, which is a different target compared to existing medications. This drug is particularly useful for patients suffering from urinary excretion disorders who do not respond adequately to current treatments. The invention includes a compound represented by a specific general formula, along with its salts, solvates, or prodrugs, aimed at preventing or treating urinary excretion disorders and improving related symptoms.

Career Highlights

Akira Ohata is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work focuses on developing effective treatments that enhance patient care and address unmet medical needs.

Collaborations

Throughout his career, Akira has collaborated with notable colleagues, including Shingo Nakatani and Tetsuya Sugiyama. These partnerships have contributed to the advancement of his research and the successful development of new therapeutic agents.

Conclusion

Akira Ohata's work exemplifies the impact of innovation in the pharmaceutical industry. His dedication to developing effective treatments for urinary excretion disorders highlights the importance of research and collaboration in advancing healthcare solutions.